Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Cannabinoid Receptor II ELISA Kit (AC2863)
Cat.#: ASET-1452
Specifications
Description Mouse Cannabinoid Receptor II ELISA Kit allows for the in vitro quantitative determination of mouse Cannabinoid Receptor II concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 37.5 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 62.5-4000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-2376 Human Stomatin ELISA Kit (AC3787) Quantitative inquiry ASET-2250 Rat PCDHB5 ELISA Kit (AC3661) Quantitative inquiry ASET-2166 Human VGF ELISA Kit (AC3577) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-2033 Rat Agrin ELISA Kit (AC3444) Quantitative inquiry ASET-1598 Human Syntenin ELISA Kit (AC3009) Quantitative inquiry ASET-1245 Human CYP1B1 ELISA Kit (AC2656) Quantitative inquiry ASET-1138 Human LUZP1 ELISA Kit (AC2549) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket